Global Diabetes Drugs Supply, Demand and Key Producers, 2024-2030

Description

Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Drugs market size is expected to reach $ 210010 million by 2030, rising at a market growth of 11.0% CAGR during the forecast period (2024-2030).

Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%.

In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

This report studies the global Diabetes Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Diabetes Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diabetes Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Diabetes Drugs total production and demand, 2019-2030, (M Units)
Global Diabetes Drugs total production value, 2019-2030, (USD Million)
Global Diabetes Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Units), (based on production site)
Global Diabetes Drugs consumption by region & country, CAGR, 2019-2030 & (M Units)
U.S. VS China: Diabetes Drugs domestic production, consumption, key domestic manufacturers and share
Global Diabetes Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Units)
Global Diabetes Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
Global Diabetes Drugs production by Application, production, value, CAGR, 2019-2030, (USD Million) & (M Units)
This report profiles key players in the global Diabetes Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, bayer, Boehringer Ingelheim, Johnson & Johnson, Takeda, Tonghua Dongbao, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diabetes Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Diabetes Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Diabetes Drugs Market, Segmentation by Type:
    Oral
    Injection

Global Diabetes Drugs Market, Segmentation by Application:
    Hospital
    Retail Pharmacy

Companies Profiled:
    Novo Nordisk
    Sanofi
    Eli Lilly
    Merck
    AstraZeneca
    bayer
    Boehringer Ingelheim
    Johnson & Johnson
    Takeda
    Tonghua Dongbao
    United Pharmaceuticals
    Ganli Pharmaceutical
    Biocon
    Conker Pharmaceuticals
    Jiangsu Wanbang
    Geropharm
    Wockhardt
    Merck Serono
    Novartis

Key Questions Answered:
1. How big is the global Diabetes Drugs market?
2. What is the demand of the global Diabetes Drugs market?
3. What is the year over year growth of the global Diabetes Drugs market?
4. What is the production and production value of the global Diabetes Drugs market?
5. Who are the key producers in the global Diabetes Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Diabetes Drugs Introduction
    1.2 World Diabetes Drugs Supply & Forecast
        1.2.1 World Diabetes Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Diabetes Drugs Production (2019-2030)
        1.2.3 World Diabetes Drugs Pricing Trends (2019-2030)
    1.3 World Diabetes Drugs Production by Region (Based on Production Site)
        1.3.1 World Diabetes Drugs Production Value by Region (2019-2030)
        1.3.2 World Diabetes Drugs Production by Region (2019-2030)
        1.3.3 World Diabetes Drugs Average Price by Region (2019-2030)
        1.3.4 North America Diabetes Drugs Production (2019-2030)
        1.3.5 Europe Diabetes Drugs Production (2019-2030)
        1.3.6 China Diabetes Drugs Production (2019-2030)
        1.3.7 Japan Diabetes Drugs Production (2019-2030)
        1.3.8 India Diabetes Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Diabetes Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Diabetes Drugs Major Market Trends

2 Demand Summary
    2.1 World Diabetes Drugs Demand (2019-2030)
    2.2 World Diabetes Drugs Consumption by Region
        2.2.1 World Diabetes Drugs Consumption by Region (2019-2024)
        2.2.2 World Diabetes Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Diabetes Drugs Consumption (2019-2030)
    2.4 China Diabetes Drugs Consumption (2019-2030)
    2.5 Europe Diabetes Drugs Consumption (2019-2030)
    2.6 Japan Diabetes Drugs Consumption (2019-2030)
    2.7 South Korea Diabetes Drugs Consumption (2019-2030)
    2.8 ASEAN Diabetes Drugs Consumption (2019-2030)
    2.9 India Diabetes Drugs Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Diabetes Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Diabetes Drugs Production by Manufacturer (2019-2024)
    3.3 World Diabetes Drugs Average Price by Manufacturer (2019-2024)
    3.4 Diabetes Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Diabetes Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Diabetes Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Diabetes Drugs in 2023
    3.6 Diabetes Drugs Market: Overall Company Footprint Analysis
        3.6.1 Diabetes Drugs Market: Region Footprint
        3.6.2 Diabetes Drugs Market: Company Product Type Footprint
        3.6.3 Diabetes Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Diabetes Drugs Production Value Comparison
        4.1.1 United States VS China: Diabetes Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Diabetes Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Diabetes Drugs Production Comparison
        4.2.1 United States VS China: Diabetes Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Diabetes Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Diabetes Drugs Consumption Comparison
        4.3.1 United States VS China: Diabetes Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Diabetes Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Diabetes Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Diabetes Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Diabetes Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Diabetes Drugs Production (2019-2024)
    4.5 China Based Diabetes Drugs Manufacturers and Market Share
        4.5.1 China Based Diabetes Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Diabetes Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Diabetes Drugs Production (2019-2024)
    4.6 Rest of World Based Diabetes Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Diabetes Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Diabetes Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Diabetes Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Diabetes Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral
        5.2.2 Injection
    5.3 Market Segment by Type
        5.3.1 World Diabetes Drugs Production by Type (2019-2030)
        5.3.2 World Diabetes Drugs Production Value by Type (2019-2030)
        5.3.3 World Diabetes Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Diabetes Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Diabetes Drugs Production by Application (2019-2030)
        6.3.2 World Diabetes Drugs Production Value by Application (2019-2030)
        6.3.3 World Diabetes Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Details
        7.1.2 Novo Nordisk Major Business
        7.1.3 Novo Nordisk Diabetes Drugs Product and Services
        7.1.4 Novo Nordisk Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Novo Nordisk Recent Developments/Updates
        7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.2 Sanofi
        7.2.1 Sanofi Details
        7.2.2 Sanofi Major Business
        7.2.3 Sanofi Diabetes Drugs Product and Services
        7.2.4 Sanofi Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Sanofi Recent Developments/Updates
        7.2.6 Sanofi Competitive Strengths & Weaknesses
    7.3 Eli Lilly
        7.3.1 Eli Lilly Details
        7.3.2 Eli Lilly Major Business
        7.3.3 Eli Lilly Diabetes Drugs Product and Services
        7.3.4 Eli Lilly Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Eli Lilly Recent Developments/Updates
        7.3.6 Eli Lilly Competitive Strengths & Weaknesses
    7.4 Merck
        7.4.1 Merck Details
        7.4.2 Merck Major Business
        7.4.3 Merck Diabetes Drugs Product and Services
        7.4.4 Merck Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck Recent Developments/Updates
        7.4.6 Merck Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Diabetes Drugs Product and Services
        7.5.4 AstraZeneca Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 bayer
        7.6.1 bayer Details
        7.6.2 bayer Major Business
        7.6.3 bayer Diabetes Drugs Product and Services
        7.6.4 bayer Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 bayer Recent Developments/Updates
        7.6.6 bayer Competitive Strengths & Weaknesses
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Details
        7.7.2 Boehringer Ingelheim Major Business
        7.7.3 Boehringer Ingelheim Diabetes Drugs Product and Services
        7.7.4 Boehringer Ingelheim Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Boehringer Ingelheim Recent Developments/Updates
        7.7.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Details
        7.8.2 Johnson & Johnson Major Business
        7.8.3 Johnson & Johnson Diabetes Drugs Product and Services
        7.8.4 Johnson & Johnson Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Johnson & Johnson Recent Developments/Updates
        7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.9 Takeda
        7.9.1 Takeda Details
        7.9.2 Takeda Major Business
        7.9.3 Takeda Diabetes Drugs Product and Services
        7.9.4 Takeda Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Takeda Recent Developments/Updates
        7.9.6 Takeda Competitive Strengths & Weaknesses
    7.10 Tonghua Dongbao
        7.10.1 Tonghua Dongbao Details
        7.10.2 Tonghua Dongbao Major Business
        7.10.3 Tonghua Dongbao Diabetes Drugs Product and Services
        7.10.4 Tonghua Dongbao Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Tonghua Dongbao Recent Developments/Updates
        7.10.6 Tonghua Dongbao Competitive Strengths & Weaknesses
    7.11 United Pharmaceuticals
        7.11.1 United Pharmaceuticals Details
        7.11.2 United Pharmaceuticals Major Business
        7.11.3 United Pharmaceuticals Diabetes Drugs Product and Services
        7.11.4 United Pharmaceuticals Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 United Pharmaceuticals Recent Developments/Updates
        7.11.6 United Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Ganli Pharmaceutical
        7.12.1 Ganli Pharmaceutical Details
        7.12.2 Ganli Pharmaceutical Major Business
        7.12.3 Ganli Pharmaceutical Diabetes Drugs Product and Services
        7.12.4 Ganli Pharmaceutical Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Ganli Pharmaceutical Recent Developments/Updates
        7.12.6 Ganli Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Biocon
        7.13.1 Biocon Details
        7.13.2 Biocon Major Business
        7.13.3 Biocon Diabetes Drugs Product and Services
        7.13.4 Biocon Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Biocon Recent Developments/Updates
        7.13.6 Biocon Competitive Strengths & Weaknesses
    7.14 Conker Pharmaceuticals
        7.14.1 Conker Pharmaceuticals Details
        7.14.2 Conker Pharmaceuticals Major Business
        7.14.3 Conker Pharmaceuticals Diabetes Drugs Product and Services
        7.14.4 Conker Pharmaceuticals Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Conker Pharmaceuticals Recent Developments/Updates
        7.14.6 Conker Pharmaceuticals Competitive Strengths & Weaknesses
    7.15 Jiangsu Wanbang
        7.15.1 Jiangsu Wanbang Details
        7.15.2 Jiangsu Wanbang Major Business
        7.15.3 Jiangsu Wanbang Diabetes Drugs Product and Services
        7.15.4 Jiangsu Wanbang Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Jiangsu Wanbang Recent Developments/Updates
        7.15.6 Jiangsu Wanbang Competitive Strengths & Weaknesses
    7.16 Geropharm
        7.16.1 Geropharm Details
        7.16.2 Geropharm Major Business
        7.16.3 Geropharm Diabetes Drugs Product and Services
        7.16.4 Geropharm Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Geropharm Recent Developments/Updates
        7.16.6 Geropharm Competitive Strengths & Weaknesses
    7.17 Wockhardt
        7.17.1 Wockhardt Details
        7.17.2 Wockhardt Major Business
        7.17.3 Wockhardt Diabetes Drugs Product and Services
        7.17.4 Wockhardt Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Wockhardt Recent Developments/Updates
        7.17.6 Wockhardt Competitive Strengths & Weaknesses
    7.18 Merck Serono
        7.18.1 Merck Serono Details
        7.18.2 Merck Serono Major Business
        7.18.3 Merck Serono Diabetes Drugs Product and Services
        7.18.4 Merck Serono Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Merck Serono Recent Developments/Updates
        7.18.6 Merck Serono Competitive Strengths & Weaknesses
    7.19 Novartis
        7.19.1 Novartis Details
        7.19.2 Novartis Major Business
        7.19.3 Novartis Diabetes Drugs Product and Services
        7.19.4 Novartis Diabetes Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 Novartis Recent Developments/Updates
        7.19.6 Novartis Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Diabetes Drugs Industry Chain
    8.2 Diabetes Drugs Upstream Analysis
        8.2.1 Diabetes Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Diabetes Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Diabetes Drugs Production Mode
    8.6 Diabetes Drugs Procurement Model
    8.7 Diabetes Drugs Industry Sales Model and Sales Channels
        8.7.1 Diabetes Drugs Sales Model
        8.7.2 Diabetes Drugs Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Diabetes Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Diabetes Drugs Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Diabetes Drugs Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Diabetes Drugs Production Value Market Share by Region (2019-2024)
 Table 5. World Diabetes Drugs Production Value Market Share by Region (2025-2030)
 Table 6. World Diabetes Drugs Production by Region (2019-2024) & (M Units)
 Table 7. World Diabetes Drugs Production by Region (2025-2030) & (M Units)
 Table 8. World Diabetes Drugs Production Market Share by Region (2019-2024)
 Table 9. World Diabetes Drugs Production Market Share by Region (2025-2030)
 Table 10. World Diabetes Drugs Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Diabetes Drugs Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Diabetes Drugs Major Market Trends
 Table 13. World Diabetes Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Units)
 Table 14. World Diabetes Drugs Consumption by Region (2019-2024) & (M Units)
 Table 15. World Diabetes Drugs Consumption Forecast by Region (2025-2030) & (M Units)
 Table 16. World Diabetes Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Diabetes Drugs Producers in 2023
 Table 18. World Diabetes Drugs Production by Manufacturer (2019-2024) & (M Units)
 Table 19. Production Market Share of Key Diabetes Drugs Producers in 2023
 Table 20. World Diabetes Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Diabetes Drugs Company Evaluation Quadrant
 Table 22. World Diabetes Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Diabetes Drugs Production Site of Key Manufacturer
 Table 24. Diabetes Drugs Market: Company Product Type Footprint
 Table 25. Diabetes Drugs Market: Company Product Application Footprint
 Table 26. Diabetes Drugs Competitive Factors
 Table 27. Diabetes Drugs New Entrant and Capacity Expansion Plans
 Table 28. Diabetes Drugs Mergers & Acquisitions Activity
 Table 29. United States VS China Diabetes Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Diabetes Drugs Production Comparison, (2019 & 2023 & 2030) & (M Units)
 Table 31. United States VS China Diabetes Drugs Consumption Comparison, (2019 & 2023 & 2030) & (M Units)
 Table 32. United States Based Diabetes Drugs Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Diabetes Drugs Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Diabetes Drugs Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Diabetes Drugs Production (2019-2024) & (M Units)
 Table 36. United States Based Manufacturers Diabetes Drugs Production Market Share (2019-2024)
 Table 37. China Based Diabetes Drugs Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Diabetes Drugs Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Diabetes Drugs Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Diabetes Drugs Production, (2019-2024) & (M Units)
 Table 41. China Based Manufacturers Diabetes Drugs Production Market Share (2019-2024)
 Table 42. Rest of World Based Diabetes Drugs Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Diabetes Drugs Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Diabetes Drugs Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Diabetes Drugs Production, (2019-2024) & (M Units)
 Table 46. Rest of World Based Manufacturers Diabetes Drugs Production Market Share (2019-2024)
 Table 47. World Diabetes Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Diabetes Drugs Production by Type (2019-2024) & (M Units)
 Table 49. World Diabetes Drugs Production by Type (2025-2030) & (M Units)
 Table 50. World Diabetes Drugs Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Diabetes Drugs Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Diabetes Drugs Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Diabetes Drugs Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Diabetes Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Diabetes Drugs Production by Application (2019-2024) & (M Units)
 Table 56. World Diabetes Drugs Production by Application (2025-2030) & (M Units)
 Table 57. World Diabetes Drugs Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Diabetes Drugs Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Diabetes Drugs Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Diabetes Drugs Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
 Table 62. Novo Nordisk Major Business
 Table 63. Novo Nordisk Diabetes Drugs Product and Services
 Table 64. Novo Nordisk Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Novo Nordisk Recent Developments/Updates
 Table 66. Novo Nordisk Competitive Strengths & Weaknesses
 Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 68. Sanofi Major Business
 Table 69. Sanofi Diabetes Drugs Product and Services
 Table 70. Sanofi Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Sanofi Recent Developments/Updates
 Table 72. Sanofi Competitive Strengths & Weaknesses
 Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 74. Eli Lilly Major Business
 Table 75. Eli Lilly Diabetes Drugs Product and Services
 Table 76. Eli Lilly Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Eli Lilly Recent Developments/Updates
 Table 78. Eli Lilly Competitive Strengths & Weaknesses
 Table 79. Merck Basic Information, Manufacturing Base and Competitors
 Table 80. Merck Major Business
 Table 81. Merck Diabetes Drugs Product and Services
 Table 82. Merck Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Merck Recent Developments/Updates
 Table 84. Merck Competitive Strengths & Weaknesses
 Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 86. AstraZeneca Major Business
 Table 87. AstraZeneca Diabetes Drugs Product and Services
 Table 88. AstraZeneca Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. AstraZeneca Competitive Strengths & Weaknesses
 Table 91. bayer Basic Information, Manufacturing Base and Competitors
 Table 92. bayer Major Business
 Table 93. bayer Diabetes Drugs Product and Services
 Table 94. bayer Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. bayer Recent Developments/Updates
 Table 96. bayer Competitive Strengths & Weaknesses
 Table 97. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
 Table 98. Boehringer Ingelheim Major Business
 Table 99. Boehringer Ingelheim Diabetes Drugs Product and Services
 Table 100. Boehringer Ingelheim Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Boehringer Ingelheim Recent Developments/Updates
 Table 102. Boehringer Ingelheim Competitive Strengths & Weaknesses
 Table 103. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
 Table 104. Johnson & Johnson Major Business
 Table 105. Johnson & Johnson Diabetes Drugs Product and Services
 Table 106. Johnson & Johnson Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Johnson & Johnson Recent Developments/Updates
 Table 108. Johnson & Johnson Competitive Strengths & Weaknesses
 Table 109. Takeda Basic Information, Manufacturing Base and Competitors
 Table 110. Takeda Major Business
 Table 111. Takeda Diabetes Drugs Product and Services
 Table 112. Takeda Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Takeda Recent Developments/Updates
 Table 114. Takeda Competitive Strengths & Weaknesses
 Table 115. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
 Table 116. Tonghua Dongbao Major Business
 Table 117. Tonghua Dongbao Diabetes Drugs Product and Services
 Table 118. Tonghua Dongbao Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Tonghua Dongbao Recent Developments/Updates
 Table 120. Tonghua Dongbao Competitive Strengths & Weaknesses
 Table 121. United Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 122. United Pharmaceuticals Major Business
 Table 123. United Pharmaceuticals Diabetes Drugs Product and Services
 Table 124. United Pharmaceuticals Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. United Pharmaceuticals Recent Developments/Updates
 Table 126. United Pharmaceuticals Competitive Strengths & Weaknesses
 Table 127. Ganli Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 128. Ganli Pharmaceutical Major Business
 Table 129. Ganli Pharmaceutical Diabetes Drugs Product and Services
 Table 130. Ganli Pharmaceutical Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Ganli Pharmaceutical Recent Developments/Updates
 Table 132. Ganli Pharmaceutical Competitive Strengths & Weaknesses
 Table 133. Biocon Basic Information, Manufacturing Base and Competitors
 Table 134. Biocon Major Business
 Table 135. Biocon Diabetes Drugs Product and Services
 Table 136. Biocon Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Biocon Recent Developments/Updates
 Table 138. Biocon Competitive Strengths & Weaknesses
 Table 139. Conker Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 140. Conker Pharmaceuticals Major Business
 Table 141. Conker Pharmaceuticals Diabetes Drugs Product and Services
 Table 142. Conker Pharmaceuticals Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Conker Pharmaceuticals Recent Developments/Updates
 Table 144. Conker Pharmaceuticals Competitive Strengths & Weaknesses
 Table 145. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
 Table 146. Jiangsu Wanbang Major Business
 Table 147. Jiangsu Wanbang Diabetes Drugs Product and Services
 Table 148. Jiangsu Wanbang Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Jiangsu Wanbang Recent Developments/Updates
 Table 150. Jiangsu Wanbang Competitive Strengths & Weaknesses
 Table 151. Geropharm Basic Information, Manufacturing Base and Competitors
 Table 152. Geropharm Major Business
 Table 153. Geropharm Diabetes Drugs Product and Services
 Table 154. Geropharm Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Geropharm Recent Developments/Updates
 Table 156. Geropharm Competitive Strengths & Weaknesses
 Table 157. Wockhardt Basic Information, Manufacturing Base and Competitors
 Table 158. Wockhardt Major Business
 Table 159. Wockhardt Diabetes Drugs Product and Services
 Table 160. Wockhardt Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. Wockhardt Recent Developments/Updates
 Table 162. Wockhardt Competitive Strengths & Weaknesses
 Table 163. Merck Serono Basic Information, Manufacturing Base and Competitors
 Table 164. Merck Serono Major Business
 Table 165. Merck Serono Diabetes Drugs Product and Services
 Table 166. Merck Serono Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Merck Serono Recent Developments/Updates
 Table 168. Merck Serono Competitive Strengths & Weaknesses
 Table 169. Novartis Basic Information, Manufacturing Base and Competitors
 Table 170. Novartis Major Business
 Table 171. Novartis Diabetes Drugs Product and Services
 Table 172. Novartis Diabetes Drugs Production (M Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 173. Novartis Recent Developments/Updates
 Table 174. Novartis Competitive Strengths & Weaknesses
 Table 175. Global Key Players of Diabetes Drugs Upstream (Raw Materials)
 Table 176. Global Diabetes Drugs Typical Customers
 Table 177. Diabetes Drugs Typical Distributors


List of Figures
 Figure 1. Diabetes Drugs Picture
 Figure 2. World Diabetes Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Diabetes Drugs Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 5. World Diabetes Drugs Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Diabetes Drugs Production Value Market Share by Region (2019-2030)
 Figure 7. World Diabetes Drugs Production Market Share by Region (2019-2030)
 Figure 8. North America Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 9. Europe Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 10. China Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 11. Japan Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 12. India Diabetes Drugs Production (2019-2030) & (M Units)
 Figure 13. Diabetes Drugs Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 16. World Diabetes Drugs Consumption Market Share by Region (2019-2030)
 Figure 17. United States Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 18. China Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 19. Europe Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 20. Japan Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 21. South Korea Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 22. ASEAN Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 23. India Diabetes Drugs Consumption (2019-2030) & (M Units)
 Figure 24. Producer Shipments of Diabetes Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Diabetes Drugs Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Diabetes Drugs Markets in 2023
 Figure 27. United States VS China: Diabetes Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Diabetes Drugs Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States VS China: Diabetes Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 30. United States Based Manufacturers Diabetes Drugs Production Market Share 2023
 Figure 31. China Based Manufacturers Diabetes Drugs Production Market Share 2023
 Figure 32. Rest of World Based Manufacturers Diabetes Drugs Production Market Share 2023
 Figure 33. World Diabetes Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 34. World Diabetes Drugs Production Value Market Share by Type in 2023
 Figure 35. Oral
 Figure 36. Injection
 Figure 37. World Diabetes Drugs Production Market Share by Type (2019-2030)
 Figure 38. World Diabetes Drugs Production Value Market Share by Type (2019-2030)
 Figure 39. World Diabetes Drugs Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World Diabetes Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Diabetes Drugs Production Value Market Share by Application in 2023
 Figure 42. Hospital
 Figure 43. Retail Pharmacy
 Figure 44. World Diabetes Drugs Production Market Share by Application (2019-2030)
 Figure 45. World Diabetes Drugs Production Value Market Share by Application (2019-2030)
 Figure 46. World Diabetes Drugs Average Price by Application (2019-2030) & (US$/Unit)
 Figure 47. Diabetes Drugs Industry Chain
 Figure 48. Diabetes Drugs Procurement Model
 Figure 49. Diabetes Drugs Sales Model
 Figure 50. Diabetes Drugs Sales Channels, Direct Sales, and Distribution
 Figure 51. Methodology
 Figure 52. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Sanofi
Eli Lilly
Merck
AstraZeneca
bayer
Boehringer Ingelheim
Johnson & Johnson
Takeda
Tonghua Dongbao
United Pharmaceuticals
Ganli Pharmaceutical
Biocon
Conker Pharmaceuticals
Jiangsu Wanbang
Geropharm
Wockhardt
Merck Serono
Novartis